xenon has been researched along with Hypertrophy, Left Ventricular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dugas, TR; Geng, YJ; Hebert, V; Huang, SL; Kim, H; Klegerman, ME; McPherson, DD; Moody, MR; Yin, X | 1 |
1 other study(ies) available for xenon and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Oral delivery of xenon for cardiovascular protection.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; Apolipoproteins E; Blood Pressure; Cardiotonic Agents; Cardiovascular System; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Mice, Inbred C57BL; Mice, Knockout; Solubility; Solutions; Xenon | 2019 |